β-caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner

Free Radical Biology and Medicine

Volumn 52, Issue 8, 2012, Pages 1325-1333

  Horváth, Béla ^a   Mukhopadhyay, Partha ^a   Kechrid, Malek ^a   Patel, Vivek ^a   Tanchian, Galin ^a   Wink, David A ^b   Gertsch, Jürg ^c   Pacher, Pál ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

(E) caryophyllene; Cannabinoid 2 receptor; Cell death; Cisplatin; Free radicals; Inflammation; Nephropathy; Oxidative stress

Indexed keywords

CANNABINOID 2 RECEPTOR; CARYOPHYLLENE; CISPLATIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; KIDNEY DISEASE; MACROPHAGE; MOUSE; NEPHROTOXICITY; NEUTROPHIL; NITRATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RENAL PROTECTION;

ANIMALS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CISPLATIN; DNA PRIMERS; KIDNEY; MALE; MICE; MICE, INBRED C57BL; NITRATES; OXIDATIVE STRESS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, CANNABINOID, CB2; SESQUITERPENES;

MURINAE; MUS; PIPER NIGRUM;

EID: 84857974399     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.01.014     Document Type: Article

References (71)

1. Gertsch, J.; Leonti, M.; Raduner, S.; Racz, I.; Chen, J. Z.; Xie, X. Q.; Altmann, K. H.; Karsak, M.; Zimmer, A. β-Caryophyllene is a dietary cannabinoid. Proc. Natl. Acad. Sci. U. S. A. 105:9099-9104; 2008.
2. Gertsch, J. Anti-inflammatory cannabinoids in diet: towards a better understanding of CB(2) receptor action? Commun. Integr. Biol. 1:26-28; 2008.
3. Sibbald, B. Conditional okay for cannabis prescription drug. Can. Med. Assoc. J. 172: 1672; 2005.
4. Kubo, I.; Chaudhuri, S. K.; Kubo, Y.; Sanchez, Y.; Ogura, T.; Saito, T.; Ishikawa, H.; Haraguchi, H. Cytotoxic and antioxidative sesquiterpenoids from Heterotheca inuloides. Planta Med. 62:427-430; 1996.
5. Singh, G.; Marimuthu, P.; de Heluani, C. S.; Catalan, C. A. Antioxidant and biocidal activities of Carum nigrum (seed) essential oil, oleoresin, and their selected components. J. Agric. Food Chem. 54:174-181; 2006.
6. Leonhardt, V.; Leal-Cardoso, J. H.; Lahlou, S.; Albuquerque, A. A.; Porto, R. S.; Celedonio, N. R.; Oliveira, A. C.; Pereira, R. F.; Silva, L. P.; Garcia-Teofilo, T. M.; Silva, A. P.; Magalhaes, P. J.; Duarte, G. P.; Coelho-de-Souza, A. N. Antispasmodic effects of essential oil of Pterodon polygalaeflorus and its main constituent β-caryophyllene on rat isolated ileum. Fundam. Clin. Pharmacol. 24:749-758; 2010.
7. Astani, A.; Reichling, J.; Schnitzler, P. Screening for antiviral activities of isolated compounds from essential oils. Evid. Based Complement. Alternat. Med. 253643; 2011. Published online 2011 February 14. doi:10.1093/ecam/nep187
8. Ghelardini, C.; Galeotti, N.; Di Cesare Mannelli, L.; Mazzanti, G.; Bartolini, A. Local anaesthetic activity of β-caryophyllene. Farmaco 56:387-389; 2001.
9. Cho, J. Y.; Chang, H. J.; Lee, S. K.; Kim, H. J.; Hwang, J. K.; Chun, H. S. Amelioration of dextran sulfate sodium-induced colitis in mice by oral administration of β-caryophyllene, a sesquiterpene. Life Sci. 80:932-939; 2007.
10. Bento, A. F.; Marcon, R.; Dutra, R. C.; Claudino, R. F.; Cola, M.; Leite, D. F.; Calixto, J. B. β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway. Am. J. Pathol. 178: 1153-1166; 2011.
11. Tambe, Y.; Tsujiuchi, H.; Honda, G.; Ikeshiro, Y.; Tanaka, S. Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, β-caryophyllene. Planta Med. 62:469-470; 1996.
12. Zwelling, L. A.; Anderson, T.; Kohn, K. W. DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum(II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity. Cancer Res. 39:365-369; 1979.
13. Pabla, N.; Dong, Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 73:994-1007; 2008.
14. Davis, C. A.; Nick, H. S.; Agarwal, A. Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide. J. Am. Soc. Nephrol. 12: 2683-2690; 2001.
15. Ramesh, G.; Reeves, W. B. TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J. Clin. Invest. 110:835-842; 2002.
16. Pan, H.; Mukhopadhyay, P.; Rajesh, M.; Patel, V.; Mukhopadhyay, B.; Gao, B.; Hasko, G.; Pacher, P. Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death. J. Pharmacol. Exp. Ther. 328:708-714; 2009.
17. Mukhopadhyay, P.; Pan, H.; Rajesh, M.; Batkai, S.; Patel, V.; Harvey-White, J.; Mukhopadhyay, B.; Hasko, G.; Gao, B.; Mackie, K.; Pacher, P. CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model. Br. J. Pharmacol. 160:657-668; 2010.
18. Mukhopadhyay, P.; Horvath, B.; Kechrid, M.; Tanchian, G.; Rajesh, M.; Naura, A. S.; Boulares, A. H.; Pacher, P. Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury. Free Radic. Biol. Med. 51: 1774-1788; 2011.
19. Mukhopadhyay, P.; Horvath, B.; Zsengeller, Z.; Zielonka, J.; Tanchian, G.; Holovac, E.; Kechrid, M.; Patel, V.; Stillman, I. E.; Parikh, S. M.; Joseph, J.; Kalyanaraman, B.; Pacher, P. Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathy. Free Radic. Biol. Med. 52: 497-506; 2012.
20. Chirino, Y. I.; Trujillo, J.; Sanchez-Gonzalez, D. J.; Martinez-Martinez, C. M.; Cruz, C.; Bobadilla, N. A.; Pedraza-Chaverri, J. Selective iNOS inhibition reduces renal damage induced by cisplatin. Toxicol. Lett. 176:48-57; 2008.
21. Guerrero-Beltran, C. E.; Mukhopadhyay, P.; Horvath, B.; Rajesh, M.; Tapia, E.; Garcia-Torres, I.; Pedraza-Chaverri, J.; Pacher, P. Sulforaphane, a natural constituent of broccoli, prevents cell death and inflammation in nephropathy. J. Nutr. Biochem. (in press).
22. Pacher, P.; Batkai, S.; Kunos, G. The endocannabinoid systemas anemerging target of pharmacotherapy. Pharmacol. Rev. 58:389-462; 2006.
23. Di Marzo, V.; Bifulco, M.; De Petrocellis, L. The endocannabinoid system and its therapeutic exploitation. Nat. Rev. Drug Discov. 3:771-784; 2004.
24. Pacher, P.; Mechoulam, R. Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog. Lipid Res. 50:193-211; 2011.
25. Legault, J.; Pichette, A. Potentiating effect of β-caryophyllene on anticancer activity of α-humulene, isocaryophyllene and paclitaxel. J. Pharm. Pharmacol. 59:1643-1647; 2007.
26. Batkai, S.; Osei-Hyiaman, D.; Pan, H.; El-Assal, O.; Rajesh, M.; Mukhopadhyay, P.; Hong, F.; Harvey-White, J.; Jafri, A.; Hasko, G.; Huffman, J. W.; Gao, B.; Kunos, G.; Pacher, P. Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury. FASEB J. 21:1788-1800; 2007.
27. Mukhopadhyay, P.; Rajesh, M.; Horvath, B.; Batkai, S.; Park, O.; Tanchian, G.; Gao, R. Y.; Patel, V.; Wink, D. A.; Liaudet, L.; Hasko, G.; Mechoulam, R.; Pacher, P. Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death. Free Radic. Biol. Med. 50:1368-1381; 2011.
28. Mukhopadhyay, P.; Rajesh, M.; Pan, H.; Patel, V.; Mukhopadhyay, B.; Batkai, S.; Gao, B.; Hasko, G.; Pacher, P. Cannabinoid-2 receptor limits inflammation, oxidative/-nitrosative stress, and cell death in nephropathy. Free Radic. Biol. Med. 48:457-467; 2010.
29. Chandra, R.; Federici, S.; Nemeth, Z. H.; Horvath, B.; Pacher, P.; Hasko, G.; Deitch, E. A.; Spolarics, Z. Female X-chromosome mosaicism for NOX2 deficiency presents unique inflammatory phenotype and improves outcome in polymicrobial sepsis. J. Immunol. 186:6465-6473; 2011.
30. Rajesh, M.; Mukhopadhyay, P.; Batkai, S.; Patel, V.; Saito, K.; Matsumoto, S.; Kashiwaya, Y.; Horvath, B.; Mukhopadhyay, B.; Becker, L.; Hasko, G.; Liaudet, L.; Wink, D. A.; Veves, A.; Mechoulam, R.; Pacher, P. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J. Am. Coll. Cardiol. 56:2115-2125; 2010.
31. Mukhopadhyay, P.; Horvath, B.; Rajesh, M.; Matsumoto, S.; Saito, K.; Batkai, S.; Patel, V.; Tanchian, G.; Gao, R. Y.; Cravatt, B. F.; Hasko, G.; Pacher, P. Fatty acid amide hydrolase is a key regulator of endocannabinoid- induced myocardial tissue injury. Free Radic. Biol. Med. 50:179-195; 2011.
32. El-Remessy, A. B.; Rajesh, M.; Mukhopadhyay, P.; Horvath, B.; Patel, V.; Al-Gayyar, M. M.; Pillai, B. A.; Pacher, P. Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line. Diabetologia 54:1567-1578; 2011.
33. Gao, R. Y.; Mukhopadhyay, P.; Mohanraj, R.; Wang, H.; Horvath, B.; Yin, S.; Pacher, P. Resveratrol attenuates azidothymidine-induced cardiotoxicity by decreasing mitochondrial reactive oxygen species generation in human cardiomyocytes. Mol. Med. Report 4:151-155; 2011.
34. Mukhopadhyay, P.; Rajesh, M.; Batkai, S.; Patel, V.; Kashiwaya, Y.; Liaudet, L.; Evgenov, O. V.; Mackie, K.; Hasko, G.; Pacher, P. CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes. Cardiovasc. Res. 85:773-784; 2010.
35. Batkai, S.;Mukhopadhyay, P.;Horvath, B.; Rajesh, M.;Gao, R. Y.;Mahadevan, A.; Amere, M.; Battista, N.; Lichtman, A.H.; Gauson, L.A.;Maccarrone, M.; Pertwee, R.G.; Pacher, P. Δ(8)-Tetrahydrocannabivarin protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress and inflammatory response involving CB(2) receptors. Br. J. Pharmacol. (2011 Apr 6, Electronic publication ahead of print). doi:10.1111/j.1476-5381.2011.01410.x.
36. Horvath, B.; Magid, L.;Mukhopadhyay, P.; Batkai, S.; Rajesh, M.; Park, O.; Tanchian, G.; Gao, R. Y.; Goodfellow, C. E.; Glass, M.; Mechoulam, R.; Pacher, P. A new cannabinoid 2 receptor agonist HU-910 attenuates oxidative stress, inflammation, and cell death associated with hepatic ischemia/reperfusion injury. Br. J. Pharmacol. (2011 Mar 30, Electronic publication ahead of print). doi:10.1111/j.1476-5381.2011.01381.x.
37. Forman, H. J.; Fukuto, J. M.; Miller, T.; Zhang, H.; Rinna, A.; Levy, S. The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal. Arch. Biochem. Biophys. 477:183-195; 2008.
38. Forman, H. J.; Maiorino, M.; Ursini, F. Signaling functions of reactive oxygen species. Biochemistry 49:835-842; 2010.
39. Pacher, P.; Beckman, J. S.; Liaudet, L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87:315-424; 2007.
40. Eiserich, J. P.; Hristova, M.; Cross, C. E.; Jones, A. D.; Freeman, B. A.; Halliwell, B.; van der Vliet, A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391:393-397; 1998.
41. Szabo, C.; Ischiropoulos, H.; Radi, R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug Discov. 6:662-680; 2007.
42. Beckman, J. S.; Koppenol, W. H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271:C1424-C1437; 1996.
43. Forman, H. J.; Torres, M. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am. J. Respir. Crit. Care Med. 166:S4-S8; 2002.
44. Ischiropoulos, H.; Zhu, L.; Beckman, J. S. Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298:446-451; 1992.
45. Radi, R.; Beckman, J. S.; Bush, K. M.; Freeman, B. A. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288:481-487; 1991.
46. Radi, R.; Cassina, A.; Hodara, R.; Quijano, C.; Castro, L. Peroxynitrite reactions and formation in mitochondria. Free Radic. Biol. Med. 33:1451-1464; 2002.
47. Szabo, C. DNA strand breakage and activation of poly-ADP ribosyltransferase: a cytotoxic pathway triggered by peroxynitrite. Free Radic. Biol. Med. 21:855-869; 1996.
48. Howlett, A. C.; Barth, F.; Bonner, T. I.; Cabral, G.; Casellas, P.; Devane, W. A.; Felder, C. C.; Herkenham, M.; Mackie, K.; Martin, B. R.; Mechoulam, R.; Pertwee, R. G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54:161-202; 2002.
49. Rajesh, M.; Pan, H.; Mukhopadhyay, P.; Batkai, S.; Osei-Hyiaman, D.; Hasko, G.; Liaudet, L.; Gao, B.; Pacher, P. Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis. J. Leukoc. Biol. 82:1382-1389; 2007.
50. Defer, N.; Wan, J.; Souktani, R.; Escoubet, B.; Perier, M.; Caramelle, P.; Manin, S.; Deveaux, V.; Bourin, M. C.; Zimmer, A.; Lotersztajn, S.; Pecker, F.; Pavoine, C. The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy. FASEB J. 23: 2120-2130; 2009.
51. Zhang, M.;Martin, B. R.; Adler, M.W.; Razdan, R. K.; Jallo, J. I.; Tuma, R. F. Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model. J. Cereb. Blood Flow Metab. 27:1387-1396; 2007.
52. Zhang, M.; Adler, M. W.; Abood, M. E.; Ganea, D.; Jallo, J.; Tuma, R. F. CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury. Microvasc. Res. 78:86-94; 2009.
53. Pacher, P.; Hasko, G. Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning. Br. J. Pharmacol. 153:252-262; 2008.
54. Louvet, A.; Teixeira-Clerc, F.; Chobert, M. N.; Deveaux, V.; Pavoine, C.; Zimmer, A.; Pecker, F.; Mallat, A.; Lotersztajn, S. Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice. Hepatology 54:1217-1226; 2011.
55. Teixeira-Clerc, F.; Belot, M. P.; Manin, S.; Deveaux, V.; Cadoudal, T.; Chobert, M. N.; Louvet, A.; Zimmer, A.; Tordjmann, T.; Mallat, A.; Lotersztajn, S. Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration. Hepatology 52:1046-1059; 2010.
56. Storr, M. A.; Keenan, C. M.; Zhang, H.; Patel, K. D.; Makriyannis, A.; Sharkey, K. A. Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis. Inflamm. Bowel Dis. 15:1678-1685; 2009.
57. Wright, K. L.; Duncan, M.; Sharkey, K. A. Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation. Br. J. Pharmacol. 153:263-270; 2008.
58. Izzo, A. A.; Sharkey, K. A. Cannabinoids and the gut: new developments and emerging concepts. Pharmacol. Ther. 126:21-38; 2010.
59. Barutta, F.; Piscitelli, F.; Pinach, S.; Bruno, G.; Gambino, R.; Rastaldi, M. P.; Salvidio, G.; Di Marzo, V.; Cavallo Perin, P.; Gruden, G. Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy. Diabetes 60: 2386-2396; 2011.
60. Aguado, T.; Carracedo, A.; Julien, B.; Velasco, G.; Milman, G.; Mechoulam, R.; Alvarez, L.; Guzman, M.; Galve-Roperh, I. Cannabinoids induce glioma stemlike cell differentiation and inhibit gliomagenesis. J. Biol. Chem. 282: 6854-6862; 2007.
61. Blazquez, C.; Carracedo, A.; Barrado, L.; Real, P. J.; Fernandez-Luna, J. L.; Velasco, G.; Malumbres, M.; Guzman, M. Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB J. 20:2633-2635; 2006.
62. Grimaldi, C.; Capasso, A. The endocannabinoid system in the cancer therapy: an overview. Curr. Med. Chem. 18:1575-1583; 2011.
63. Gustafsson, K.; Wang, X.; Severa, D.; Eriksson, M.; Kimby, E.; Merup, M.; Christensson, B.; Flygare, J.; Sander, B. Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation. Int. J. Cancer 123:1025-1033; 2008.
64. Gertsch, J.; Pertwee, R. G.; Di Marzo, V. Phytocannabinoids beyond the Cannabis plant-do they exist? Br. J. Pharmacol. 160:523-529; 2010.
65. Rajesh, M.; Mukhopadhyay, P.; Batkai, S.; Hasko, G.; Liaudet, L.; Huffman, J. W.; Csiszar, A.; Ungvari, Z.; Mackie, K.; Chatterjee, S.; Pacher, P. CB2-receptor stimulation attenuates TNF-α-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion. Am. J. Physiol. Heart Circ. Physiol. 293:H2210-H2218; 2007.
66. Dursun, B.; He, Z.; Somerset, H.; Oh, D. J.; Faubel, S.; Edelstein, C. L. Caspases and calpain are independent mediators of cisplatin-induced endothelial cell necrosis. Am. J. Physiol. Renal Physiol. 291:F578-F587; 2006.
67. Montecucco, F.; Lenglet, S.; Braunersreuther, V.; Burger, F.; Pelli, G.; Bertolotto, M.; Mach, F.; Steffens, S. CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion. J. Mol. Cell. Cardiol. 46:612-620; 2009.
68. Steffens, S.; Veillard, N. R.; Arnaud, C.; Pelli, G.; Burger, F.; Staub, C.; Karsak, M.; Zimmer, A.; Frossard, J. L.; Mach, F. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature 434:782-786; 2005.
69. Montecucco, F.; Di Marzo, V.; da Silva, R. F.; Vuilleumier, N.; Capettini, L.; Lenglet, S.; Pagano, S.; Piscitelli, F.; Quintao, S.; Bertolotto, M.; Pelli, G.; Galan, K.; Pilet, L.; Kuzmanovic, K.; Burger, F.; Pane, B.; Spinella, G.; Braunersreuther, V.; Gayet- Ageron, A.; Pende, A.; Viviani, G. L.; Palombo, D.; Dallegri, F.; Roux-Lombard, P.; Santos, R. A.; Stergiopulos, N.; Steffens, S.; Mach, F. The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques. Eur. Heart J. (in press).
70. Asakawa, Y.; Taira, Z.; Takemoto, T.; Ishida, T.; Kido, M.; Ichikawa, Y. X-ray crystal structure analysis of 14-hydroxycaryophyllene oxide, a new metabolite of (-)- caryophyllene, in rabbits. J. Pharm. Sci. 70:710-711; 1981.
71. Asakawa, Y.; Ishida, T.; Toyota, M.; Takemoto, T. Terpenoid biotransformation in mammals. IV Biotransformation of (+)-longifolene, (-)-caryophyllene, (-)- caryophyllene oxide, (-)-cyclocolorenone, (+)-nootkatone, (-)-elemol, (-)- abietic acid and (+)-dehydroabietic acid in rabbits. Xenobiotica 16:753-767; 1986.